Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina

Health Services Research

Volumn 50, Issue 3, 2015, Pages 768-789

  Van Der Steen, Alex ^a   Knudsen, Amy B ^b   Van Hees, Frank ^a   Walter, Gailya P ^c   Berger, Franklin G ^c   Daguise, Virginie G ^d   Kuntz, Karen M ^e   Zauber, Ann G ^f   Van Ballegooijen, Marjolein ^a   Lansdorp Vogelaar, Iris ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

budget restriction; CRC screening; low income; uninsured population

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; FECAL IMMUNOCHEMICAL TEST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; IMMUNOCHEMISTRY; LOWEST INCOME GROUP; MALE; MEDICALLY UNINSURED; MICROSIMULATION MODEL; PATIENT COMPLIANCE; SENSITIVITY ANALYSIS; SIMULATION; UNITED STATES; AFRICAN AMERICAN; AGE; CAUCASIAN; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; ETHNOLOGY; FECES; IMMUNOASSAY; MIDDLE AGED; POVERTY; PROCEDURES; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

AFRICAN AMERICANS; AGE FACTORS; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FECES; HUMANS; IMMUNOASSAY; MEDICALLY UNINSURED; MIDDLE AGED; PATIENT COMPLIANCE; POVERTY; SEX FACTORS; SOUTH CAROLINA;

EID: 84929676996     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12246     Document Type: Article

References (43)

1. American Cancer Society. 2005. Colorectal Cancer Facts & Figures: Special Edition, 2005 [accessed October 6, 2014]. Available at http://www.cancer.org/acs/groups/content/@nho/documents/document/caff2005cr4pwsecuredpdf.pdf
2. Arminski, T. C., and, D. W. McLean,. 1964. " Incidence and Distribution of Adenomatous Polyps of the Colon and Rectum Based on 1,000 Autopsy Examinations." Diseases of the Colon and Rectum 7: 249-61.
3. Atkin, W. S., R. Edwards, I. Kralj-Hans, K. Wooldrage, A. R. Hart, J. M. Northover, D. M. Parkin, J. Wardle, S. W. Duffy, J. Cuzick, and, U. K. F. S. T. Investigators,. 2010. " Once-Only Flexible Sigmoidoscopy Screening in Prevention of Colorectal Cancer: A Multicentre Randomised Controlled Trial." Lancet 375 (9726): 1624-33.
4. Blatt, L., 1961. " Polyps of the Colon and Rectum: Incidence and Distribution." Diseases of the Colon and Rectum 4: 277-82.
5. Bombi, J. A., 1988. " Polyps of the Colon in Barcelona, Spain. An Autopsy Study." Cancer 61 (7): 1472-6.
6. Bureau of Labor Statistics. 2013. " Bureau of Labor Statistics " [accessed on May 16, 2014]. Available at http://www.bls.gov/oes/current/oes-nat.htm
7. Chapman, I., 1963. " Adenomatous Polypi of Large Intestine: Incidence and Distribution." Annals of Surgery 157: 223-6.
8. Clark, J. C., Y. Collan, T. J. Eide, J. Esteve, S. Ewen, N. M. Gibbs, O. M. Jensen, E. Koskela, R. MacLennan, J. G. Simpson, H. Stalsberg, and, D. G. Zaridze,. 1985. " Prevalence of Polyps in an Autopsy Series from Areas with Varying Incidence of Large-Bowel Cancer." International Journal of Cancer 36 (2): 179-86.
9. Consumer Pricing Index. 2014. [accessed on March 19, 2014]. Available at http://www.bls.gov/cpi/#tables
10. Gatto, N. M., H. Frucht, V. Sundararajan, J. S. Jacobson, V. R. Grann, and, A. I. Neugut,. 2003. " Risk of Perforation after Colonoscopy and Sigmoidoscopy: A Population-Based Study." Journal of the National Cancer Institute 95 (3): 230-6.
11. Grubbs, S. S., B. N. Polite, J. Carney, Jr., W. Bowser, J. Rogers, N. Katurakes, P. Hess, and, E. D. Paskett,. 2013. " Eliminating Racial Disparities in Colorectal Cancer in the Real World: It Took a Village." Journal of Clinical Oncology 31 (16): 1928-30.
12. Hardcastle, J. D., J. O. Chamberlain, M. H. Robinson, S. M. Moss, S. S. Amar, T. W. Balfour, P. D. James, and, C. M. Mangham,. 1996. " Randomised Controlled Trial of Faecal-Occult-Blood Screening for Colorectal Cancer." Lancet 348 (9040): 1472-7.
13. Jass, J. R., P. J. Young, and, E. M. Robinson,. 1992. " Predictors of Presence, Multiplicity, Size and Dysplasia of Colorectal Adenomas. A Necropsy Study in New Zealand." Gut 33 (11): 1508-14.
14. Johannsen, L. G., O. Momsen, and, N. O. Jacobsen,. 1989. " Polyps of the Large Intestine in Aarhus, Denmark. An Autopsy Study." Scandinavian Journal of Gastroenterology 24 (7): 799-806.
15. Joseph, D. A., A. S. DeGroff, N. S. Hayes, F. L. Wong, and, M. Plescia,. 2011. " The Colorectal Cancer Control Program: Partnering to Increase Population Level Screening." Gastrointestinal Endoscopy 73 (3): 429-34.
16. Kronborg, O., C. Fenger, J. Olsen, O. D. Jorgensen, and, O. Sondergaard,. 1996. " Randomised Study of Screening for Colorectal Cancer with Faecal-Occult-Blood Test." Lancet 348 (9040): 1467-71.
17. Kuntz, K. M., I. Lansdorp-Vogelaar, C. M. Rutter, A. B. Knudsen, M. van Ballegooijen, J. E. Savarino, E. J. Feuer, and, A. G. Zauber,. 2011. " A Systematic Comparison of Microsimulation Models of Colorectal Cancer: The Role of Assumptions about Adenoma Progression." Medical Decision Making 31 (4): 530-9.
18. Lansdorp-Vogelaar, I., A. B. Knudsen, and, H. Brenner,. 2011. " Cost-Effectiveness of Colorectal Cancer Screening." Epidemiologic Reviews 33 (1): 88-100.
19. Lansdorp-Vogelaar, I., M. van Ballegooijen, R. Boer, A. Zauber, and, J. D. Habbema,. 2009. " A Novel Hypothesis on the Sensitivity of the Fecal Occult Blood Test: Results of a Joint Analysis of Three Randomized Controlled Trials." Cancer 115 (11): 2410-9.
20. Lieberman, D. A., D. K. Rex, S. J. Winawer, F. M. Giardiello, D. A. Johnson, and, T. R. Levin, and C. United States Multi-Society Task Force on Colorectal. 2012. " Guidelines for Colonoscopy Surveillance after Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer." Gastroenterology 143 (3): 844-57.
21. Mandel, J. S., J. H. Bond, T. R. Church, D. C. Snover, G. M. Bradley, L. M. Schuman, and, F. Ederer,. 1993. " Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. Minnesota Colon Cancer Control Study." New England Journal of Medicine 328 (19): 1365-71.
22. Naishadham, D., I. Lansdorp-Vogelaar, R. Siegel, V. Cokkinides, and, A. Jemal,. 2011. " State Disparities in Colorectal Cancer Mortality Patterns in the United States." Cancer Epidemiology, Biomarkers and Prevention 20 (7): 1296-302.
23. National Center for Health Statistics. 2011. [accessed on April 18, 2013]. Available at http://www.cdc.gov/nchs/products/pubs/pubd/lftbls/
24. Rex, D. K., D. A. Johnson, J. C. Anderson, P. S. Schoenfeld, C. A. Burke, J. M. Inadomi, and G. American College of. 2009. " American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2009 [Corrected]." American Journal of Gastroenterology 104 (3): 739-50.
25. Rickert, R. R., O. Auerbach, L. Garfinkel, E. C. Hammond, and, J. M. Frasca,. 1979. " Adenomatous Lesions of the Large Bowel: An Autopsy Survey." Cancer 43 (5): 1847-57.
26. van Rijn, J. C., J. B. Reitsma, J. Stoker, P. M. Bossuyt, S. J. van Deventer, and, E. Dekker,. 2006. " Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review." American Journal of Gastroenterology 101 (2): 343-50.
27. van Roon, A. H., S. L. Goede, M. van Ballegooijen, A. J. van Vuuren, C. W. Looman, K. Biermann, J. C. Reijerink, H. Mannetje, A. C. van der Togt, J. D. Habbema, M. E. van Leerdam, and, E. J. Kuipers,. 2013. " Random Comparison of Repeated Faecal Immunochemical Testing at Different Intervals for Population-Based Colorectal Cancer Screening." Gut 62 (3): 409-15.
28. Schoen, R. E., P. F. Pinsky, J. L. Weissfeld, L. A. Yokochi, T. Church, A. O. Laiyemo, R. Bresalier, T. Hickey, T. Riley, and, P. C. Prorok,. 2012. " Colorectal Cancers Not Detected by Screening Flexible Sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial." Gastrointestinal Endoscopy 75 (3): 612-20.
29. Segnan, N., P. Armaroli, L. Bonelli, M. Risio, S. Sciallero, M. Zappa, B. Andreoni, A. Arrigoni, L. Bisanti, C. Casella, C. Crosta, F. Falcini, F. Ferrero, A. Giacomin, O. Giuliani, A. Santarelli, C. B. Visioli, R. Zanetti, W. S. Atkin, and, C. Senore, and S. W. Group. 2011. " Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-Up Findings of the Italian Randomized Controlled Trial-SCORE." Journal of the National Cancer Institute 103 (17): 1310-22.
30. Shapiro, J. A., C. N. Klabunde, T. D. Thompson, M. R. Nadel, L. C. Seeff, and, A. White,. 2012. " Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey." Cancer Epidemiology, Biomarkers and Prevention 21 (6): 895-904.
31. Siegel, R., D. Naishadham, and, A. Jemal,. 2013. " Cancer Statistics, 2013." CA: A Cancer Journal for Clinicians 63 (1): 11-30.
32. Subramanian, S., G. Bobashev, and, R. J. Morris,. 2010. " When Budgets Are Tight, There Are Better Options Than Colonoscopies for Colorectal Cancer Screening." Health Affairs (Millwood) 29 (9): 1734-40.
33. Surveillance Epidemiology and End Results (SEER) Program. 2003. " SEER∗Stat Database: Incidence-SEER 9 Regs Public Use. Nov 2003 Sub (1973-2001), DCCPS, Surveillance Research Program, Cancer Statistics Branch. Based on the November 2003 submission. Bethesda, MD: National Cancer Institute; April 2004 " [accessed on March 5, 2010, 2003]. Available at http://www.seer.cancer.gov
34. U.S. Census Bureau. 2012. Current Population Survey, Annual Social and Economic Supplement [accessed October 6, 2014]. Available at http://www.census.gov/2010census/
35. U.S. Preventive Services Task Force. 2008. " Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement." Annals of Internal Medicine 149 (9): 627-37.
36. Vatn, M. H., and, H. Stalsberg,. 1982. " The Prevalence of Polyps of the Large Intestine in Oslo: An Autopsy Study." Cancer 49 (4): 819-25.
37. Warren, J. L., C. N. Klabunde, A. B. Mariotto, A. Meekins, M. Topor, M. L. Brown, and, D. F. Ransohoff,. 2009. " Adverse Events after Outpatient Colonoscopy in the Medicare Population." Annals of Internal Medicine 150 (12): 849-57, W152.
38. Williams, A. R., B. A. Balasooriya, and, D. W. Day,. 1982. " Polyps and Cancer of the Large Bowel: A Necropsy Study in Liverpool." Gut 23 (10): 835-42.
39. Wilschut, J. A., L. Hol, E. Dekker, J. B. Jansen, M. E. Van Leerdam, I. Lansdorp-Vogelaar, E. J. Kuipers, J. D. Habbema, and, M. Van Ballegooijen,. 2011. " Cost-Effectiveness Analysis of a Quantitative Immunochemical Test for Colorectal Cancer Screening." Gastroenterology 141 (5): 1648-55 e1.
40. Yabroff, K. R., J. L. Warren, K. Knopf, W. W. Davis, and, M. L. Brown,. 2005. " Estimating Patient Time Costs Associated with Colorectal Cancer Care." Medical Care 43 (7): 640-8.
41. Yabroff, K. R., W. W. Davis, E. B. Lamont, A. Fahey, M. Topor, M. L. Brown, and, J. L. Warren,. 2007. " Patient Time Costs Associated with Cancer Care." Journal of the National Cancer Institute 99 (1): 14-23.
42. Zauber, A., I. Lansdorp-Vogelaar, J. Wilschut, A. B. Knudsen, M. van Ballegooijen, and, K. M. Kuntz,. 2007. Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer: Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. [available at October 6, 2014]. Available at http://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id52TA.pdf
43. Zauber, A. G., I. Lansdorp-Vogelaar, A. B. Knudsen, J. Wilschut, M. van Ballegooijen, and, K. M. Kuntz,. 2008. " Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force." Annals of Internal Medicine 149 (9): 659-69.